Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Victor Moreno Garcia"'
Autor:
Debra Richardson, Jose Alejandro Perez Fidalgo, Antonio Gonzalez-Martin, Ana Oaknin, Erika Hamilton, John Hays, Bhavana Pothuri, Kyriakos Papadopoulos, Sara Taylor, Marilyn Huang, Yeh-Chen Lee, Thomas Krivak, Victor Moreno-Garcia, Emiliano Calvo, Leslie Randall, David Starks, Malcom Ross, Linda Duska, Bo Gao, Robert Poka, Emily Putiri, Jamie Barrett, Leslie Demars, Nicole Concin
Publikováno v:
E-Posters (Trials In Progress).
Autor:
Richard H. Wilson, Stan B. Kaye, Andre T. Brunetto, Jean-Charles Soria, Nicolas Penel, Patrick Schöffski, Ruth Plummer, Carlos Gomez-Roca, Josep Tabernero, Silvia Marsoni, Jan H.M. Schellens, Philippe A. Cassier, Jeff Evans, Gianluca Del Conte, Victor Moreno Garcia, Rafael Morales-Barrera, Jaap Verweij, David Olmos, Elisa Gallerani, Emile E. Voest
Publikováno v:
Clinical Cancer Research, 20(22), 5663. American Association for Cancer Research Inc.
Clinical Cancer Research, 20(22), 5663-5671. American Association for Cancer Research Inc.
Clinical Cancer Research, 20(22), 5663-5671. American Association for Cancer Research Inc.
Introduction: Because a dose–response relationship is characteristic of conventional chemotherapy, this concept is widely used for the development of novel cytotoxic (CTX) drugs. However, the need to reach the MTD to obtain optimal benefit with mol
Autor:
Miguel Ángel García-Cabezas, Juan Carlos Lacal, Joan Maurel, Jose Javier Sanchez, Victor Moreno Garcia, César Gómez-Raposo, Paloma Cejas, Jaime Feliu, Carlos Fernández-Martos, Beatriz Castelo, Juan Moreno Rubio, Emilio Burgos, Javier de Castro, María Teresa Gómez del Pulgar, Enrique Casado, Miriam López-Gómez, Manuel González-Barón, Francisco Zambrana, Cristobal Belda-Iniesta, Pilar Vázquez, María Sereno, Rocío López
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Purpose]: Management of locally advanced rectal cancer (RC) consists of neoadjuvant chemoradiotherapy (CRT) with fluoropyrimidines, followed by total mesorectal excision. We sought to evaluate the expression of selected genes, some of which were der
Publikováno v:
Clinical Cancer Research. 18:3750-3761
Antiangiogenic therapies are now well established in oncology clinical practice; however, despite initial optimism, the results of late-phase trials, especially in the adjuvant setting, have largely proved disappointing. In the context of metastatic
Autor:
Miguel Ángel García-Cabezas, Emilio Burgos, Beatriz Castelo, Damián García-Olmo, Paloma Cejas, Montserrat Blanco, Cristobal Belda-Iniesta, Jaime Feliu, Enrique Casado, Jose Javier Sanchez, Benito Sánchez-Llamas, Manuel González-Barón, Rosa Miquel, Carlos Fernández-Martos, Javier de Castro, María Sereno, Victor Moreno Garcia, Joan Maurel, Noemi Mancenido
Publikováno v:
Clinical Cancer Research. 17:4145-4154
Purpose: Preoperative chemoradiotherapy (CRT) is the treatment of choice for rectal cancer (RC), but half of the patients do not respond, suffer unnecessary toxicities, and surgery delays. We aimed to develop a model that could predict a clinically m
Autor:
Victor Moreno Garcia, Udai Banerji, Montserrat Blanco Codesido, Joanna Vitfell Pedersen, Andre T. Brunetto, Dionysis Papadatos-Pastos, Sophia Frentzas, Leonardo Trani, L Rhoda Molife, Martina Puglisi
Publikováno v:
Oncology. 81:135-140
Introduction: First-line treatment options utilizing chemotherapy and cytokine-based treatments for patients with metastatic melanoma (MM) are unsatisfactory. We analyzed the clinical outcomes of patients with MM treated in phase I trials of novel ag
Autor:
Abrahim Fandi, D'Angiolella Paola, Giulia Tonini, Elena Garralda, Elizabeth Ruth Plummer, Michele Spina, Guy Jerusalem, Mario Cioce, Paolo Mazzei, Cecilia Simonelli, Serena Buontempo, Giuseppe Merlino, Josep Tabernero, Monica Binaschi, Victor Moreno Garcia, Andrea Pellacani, Cristina Rossi, Mariagiuseppa Matera, Christian Rohlff, Maria de Miguel
Publikováno v:
Journal of Clinical Oncology. 36:TPS2606-TPS2606
TPS2606Background: MEN1309/OBT076 is a DM4-loaded Antibody Drug Conjugate (ADC), directed against CD205/Ly75, a type I transmembrane surface protein belonging to the macrophage mannose receptor fam...
Autor:
Maria Eugenia Olmedo Garcia, Marta Martin, Matthew G. Fury, Emiliano Calvo, M. Feng, Raid Aljumaily, Kyriakos P. Papadopoulos, P. Rietschel, Kosalai Kal Mohan, Jingjin Li, Victor Moreno Garcia, Lee S. Rosen, Elizabeth Stankevich, Tracey Rowlands
Publikováno v:
Journal of Clinical Oncology. 36:e21057-e21057
e21057Background: NSCLC accounts for ~85% of lung cancers; most patients (pts) are at an advanced stage at the time of diagnosis. Cemiplimab (REGN2810) is being investigated for the treatment of NS...
Publikováno v:
Cancer discovery. 1(3)
Current anticancer drug development still largely follows the classic designs developed for chemotherapeutic agents over the past 4 to 5 decades, remaining slow, costly, and inefficient, with continuing high risks of costly late drug attrition. A Pha
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 10(3)
Follicular lymphoma is the second most common lymphoma throughout the world. Its course is usually indolent. Affection of Central Nervous System by a follicular lymphoma is usually as primary disease, and secondary affection is usually due to high-gr